Skip to main content
I

Incyte

Incyte is a global biopharmaceutical company discovering and developing medicines in hematology, oncology, inflammation and autoimmunity, and dermatology, with over 3,000 employees.

Incyte is a global biopharmaceutical company that discovers and develops medicines for serious unmet medical needs. Its research and clinical work spans hematology, oncology, inflammation and autoimmunity (including dermatology), and health outcomes research. The company markets a portfolio of approved medicines across these disease areas and maintains a pipeline of clinical-stage candidates, alongside partnered programs.

Employing more than 3,000 people, of whom roughly 1,000 work in research and clinical development, Incyte brings together scientists, chemists, biologists, clinicians and commercial teams. Headquarters are in Wilmington, Delaware, with a presence across North America, Europe and Asia.

The company describes its mission as "Solve On" and emphasises rigorous science and collaboration, with a stated focus on the urgency faced by patients with serious diseases. It also supports independent research intended to deepen disease understanding and generate additional health outcomes evidence.

1 Open job